Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pediatr Emerg Care ; 31(11): 748-52, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26535496

RESUMEN

OBJECTIVES: The objectives of this study were to determine the causes, location of cardiopulmonary arrest (CPA) in children, and demographics of cardiopulmonary resuscitation (CPR) in Turkish pediatric emergency departments and pediatric intensive care units (PICUs) and to determine survival rates and morbidities for both in-hospital and out-of-hospital CPA. METHODS: This multicenter descriptive study was conducted prospectively between January 15 and July 15, 2011, at 18 centers (15 PICUs, 3 pediatric emergency departments) in Turkey. RESULTS: During the study period, 239 children had received CPR. Patients' average age was 42.4 (SD, 58.1) months. The most common cause of CPA was respiratory failure (119 patients [49.8%]). The location of CPA was the PICU in 168 (68.6%), hospital wards in 43 (18%), out-of-hospital in 24 (10%), and pediatric emergency department in 8 patients (3.3%). The CPR duration was 30.7 (SD, 23.6) minutes (range, 1-175 minutes) and return of spontaneous circulation was achieved in 107 patients (44.8%) after the first CPR. Finally, 58 patients (24.2%) were discharged from hospital; survival rates were 26% and 8% for in-hospital and out-of-hospital CPA, respectively (P = 0.001). Surviving patients' average length of hospital stay was 27.4 (SD, 39.2) days. In surviving patients, 19 (32.1%) had neurologic disability. CONCLUSION: Pediatric CPA in both the in-hospital and out-of-hospital setting has a poor outcome.


Asunto(s)
Reanimación Cardiopulmonar , Paro Cardíaco/terapia , Preescolar , Servicio de Urgencia en Hospital , Femenino , Paro Cardíaco/etiología , Paro Cardíaco/mortalidad , Humanos , Unidades de Cuidado Intensivo Pediátrico , Masculino , Paro Cardíaco Extrahospitalario/etiología , Paro Cardíaco Extrahospitalario/mortalidad , Paro Cardíaco Extrahospitalario/terapia , Estudios Prospectivos , Tasa de Supervivencia , Turquía
2.
Pediatr Emerg Care ; 23(5): 314-7, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17505274

RESUMEN

Colchicine poisoning is an uncommon, but potentially life-threatening, toxicologic emergency. The clinical features associated with overdose and the options for treatment are discussed. Colchicine poisoning typically shows 3 phases: initially, gastrointestinal symptoms predominate; in the second phase, multiorgan failure may occur, possibly leading to death. If the patient survives, the third phase of recovery follows, during which the patient often presents with hair loss. Early fatality is due to cardiovascular collapse and respiratory failure; however, pancytopenia and overwhelming septicemia can occur later. All patients suspected of having colchicine intoxication because of its unpredictable outcome should be managed according to the principles of intensive care, irrespective of the actual degree of poisoning. In those patients who survive the initial phase of poisoning, filgrastim (granulocyte colony-stimulating factor) offers an effective method of treating pancytopenia and preventing overwhelming septicemia. Daily monitoring of the patients' hematological status is strongly recommended. We are reporting a case of previously healthy girl who developed a multisystem organ failure after colchicine intoxication. The patient recovered completely and had no residual outcome.


Asunto(s)
Colchicina/envenenamiento , Insuficiencia Multiorgánica/inducido químicamente , Enfermedad Aguda , Alopecia/inducido químicamente , Ataxia/inducido químicamente , Transfusión Sanguínea , Manejo de Caso , Preescolar , Terapia Combinada , Coagulación Intravascular Diseminada/inducido químicamente , Coagulación Intravascular Diseminada/tratamiento farmacológico , Dobutamina/uso terapéutico , Femenino , Fluidoterapia , Furosemida/uso terapéutico , Gastroenteritis/inducido químicamente , Humanos , Hiponatremia/inducido químicamente , Hiponatremia/complicaciones , Hipotensión/inducido químicamente , Insuficiencia Multiorgánica/tratamiento farmacológico , Insuficiencia Multiorgánica/terapia , Pancitopenia/inducido químicamente , Pancitopenia/terapia , Fenitoína/efectos adversos , Fenitoína/uso terapéutico , Intoxicación/sangre , Intoxicación/tratamiento farmacológico , Intoxicación/terapia , Convulsiones/tratamiento farmacológico , Convulsiones/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA